Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 2009

View Archived Issues

FDA grants priority review to Shire's NDA for velaglucerase alfa in Gaucher disease

Oroxcell discovers novel sodium channel inhibitors for the treatment of pain

Graceway acquires worldwide rights to GS-9191 from Gilead Sciences

Phase III results show activity of omiganan 1% gel against catheter-related infections

FDA grants clearance to Arkray's Glucocard Vital blood glucose monitoring system

Bupropion improves hypoactive sexual desire disorder in women

Guided Therapeutics reports trial results of LightTouch in cervical cancer detection

Interim results of phase III study with CIMAvax EGF vaccine in NSCLC reported

Tesofensine effects on weight lead to phase III investigation

Subcutaneous abatacept may be delivered without methotrexate to treat RA

Pilot clinical data suggest beneficial effects of transdermal nicotine in mild cognitive impairment

Azathioprine superior to mycophenolate mofetil as maintenance therapy for ANCA-AAV

Gruenenthal presents ORL1 and mu-opioid receptor ligands as analgesics

IRM claims GDIR ligands for the treatment of diabetes and obesity

China Medical Technologies receives approval for its leukemia gene detection probe

Compugen discovers genetic biomarker for predisposition to type 2 diabetes

Evotec and Boehringer Ingelheim extend research collaboration

Bristol-Myers Squibb discloses IGF-1R inhibitors for the treatment of cancer

Daval's Aimspro is designated orphan drug for amyotrophic lateral sclerosis

Xoma to develop XOMA-052 antibody for cardiovascular diseases

Genmab starts phase III trial of ofatumumab in diffuse large B-cell lymphoma

Health Canada accepts for review EpiCept's NDS for Ceplene in AML

FDA extends review date of GSK's and XenoPort's NDA for gabapentin enacarbil

Concert Pharmaceuticals begins phase Ib clinical trial of HIV therapeutic CTP-518

D-Pharm enters into collaboration with Wanbang Biopharmaceuticals for DP-b99

GlaxoSmithKline reports third quarter 2009 results

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...